TR200402277T2 - Nörotik düzensizliklerin tedavisi - Google Patents

Nörotik düzensizliklerin tedavisi

Info

Publication number
TR200402277T2
TR200402277T2 TR2004/02277T TR200402277T TR200402277T2 TR 200402277 T2 TR200402277 T2 TR 200402277T2 TR 2004/02277 T TR2004/02277 T TR 2004/02277T TR 200402277 T TR200402277 T TR 200402277T TR 200402277 T2 TR200402277 T2 TR 200402277T2
Authority
TR
Turkey
Prior art keywords
treatment
disorder
neurotic disorders
anxiety disorder
neurotic
Prior art date
Application number
TR2004/02277T
Other languages
English (en)
Inventor
Sanchez Connie
Hogg Sandra
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8099796&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200402277(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of TR200402277T2 publication Critical patent/TR200402277T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

Eskitalopramin (sitalopramin S-(+)-enantiomeri) ya da bunun farmasötik olarak kabul edilebilir bir tuzunun aralarinda angziyete durumlari, özellikle genellestirilmis angziyete düzensizligi ve sosyal angziyete düzensizligi, travma sonrasi stres düzensizligi, obsesif kompülsif düzensizlik ve panik ataklarin bulundugu nörotik düzensizliklerin tedavisinde kullanisli bir ilacin hazirlanmasi için kullanimi.
TR2004/02277T 1999-07-08 2000-07-07 Nörotik düzensizliklerin tedavisi TR200402277T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199900991 1999-07-08
PCT/DK2000/000377 WO2001003694A1 (en) 1999-07-08 2000-07-07 Treatment of neurotic disorders

Publications (1)

Publication Number Publication Date
TR200402277T2 true TR200402277T2 (tr) 2005-01-24

Family

ID=8099796

Family Applications (4)

Application Number Title Priority Date Filing Date
TR2004/02277T TR200402277T2 (tr) 1999-07-08 2000-07-07 Nörotik düzensizliklerin tedavisi
TR2004/02275T TR200402275T2 (tr) 1999-07-08 2000-07-07 Nörotik düzensizliklerin tedavisi
TR2004/02276T TR200402276T2 (tr) 1999-07-08 2000-07-07 Nörotik düzensizliklerin tedavisi
TR2002/00014T TR200200014T2 (tr) 1999-07-08 2000-07-07 Nörotik düzensizliklerin tedavisi.

Family Applications After (3)

Application Number Title Priority Date Filing Date
TR2004/02275T TR200402275T2 (tr) 1999-07-08 2000-07-07 Nörotik düzensizliklerin tedavisi
TR2004/02276T TR200402276T2 (tr) 1999-07-08 2000-07-07 Nörotik düzensizliklerin tedavisi
TR2002/00014T TR200200014T2 (tr) 1999-07-08 2000-07-07 Nörotik düzensizliklerin tedavisi.

Country Status (38)

Country Link
US (6) US7271194B2 (tr)
EP (4) EP1440690A3 (tr)
JP (1) JP4773011B2 (tr)
KR (1) KR100604176B1 (tr)
CN (1) CN1198610C (tr)
AR (1) AR021155A1 (tr)
AT (1) ATE339955T1 (tr)
AU (6) AU782514B2 (tr)
BG (4) BG110466A (tr)
BR (1) BR0011578A (tr)
CA (4) CA2373757C (tr)
CL (3) CL2008003939A1 (tr)
CO (1) CO5190674A1 (tr)
CY (1) CY1105806T1 (tr)
CZ (1) CZ200270A3 (tr)
DE (1) DE60030861T2 (tr)
DK (1) DK1200081T3 (tr)
EA (1) EA006555B1 (tr)
ES (1) ES2272298T3 (tr)
HK (1) HK1048069B (tr)
HR (1) HRP20010820A2 (tr)
HU (1) HUP0201791A3 (tr)
IL (5) IL146131A0 (tr)
IS (1) IS6137A (tr)
ME (2) MEP2508A (tr)
MX (1) MXPA01011626A (tr)
MY (1) MY143278A (tr)
NO (4) NO329021B1 (tr)
PL (1) PL352030A1 (tr)
PT (1) PT1200081E (tr)
SI (1) SI1200081T1 (tr)
SK (1) SK82002A3 (tr)
TR (4) TR200402277T2 (tr)
TW (1) TWI232101B (tr)
UA (1) UA77645C2 (tr)
WO (1) WO2001003694A1 (tr)
YU (1) YU78701A (tr)
ZA (1) ZA200108856B (tr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR021155A1 (es) 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
IL153988A0 (en) * 2000-07-21 2003-07-31 Lundbeck & Co As H Novel compounds and their use as glycine transport inhibitors
US20040198809A1 (en) * 2001-05-01 2004-10-07 Connie Sanchez Use of enantiomeric pure escitalopram
TR200400189T2 (tr) 2001-07-31 2004-12-21 H.Lundbeck A/S Esitalopram içeren kristal yapılı bileşim.
AU2003237524A1 (en) * 2002-07-08 2004-01-23 University Of Florida Use of ssri inhibitors to prevent or ameliorate trauma-related psychological disorders
PT1578738E (pt) * 2002-12-23 2008-04-11 Lundbeck & Co As H Bromidrato de escitalopram e um método para a sua preparação
US20050137255A1 (en) * 2002-12-23 2005-06-23 H. Lundbeck A/S Crystalline escitalopram hydrobromide and methods for preparing the same
AU2003223105A1 (en) * 2003-03-24 2004-10-18 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
US20090093461A1 (en) * 2003-07-02 2009-04-09 Astrazeneca Ab Methods of Treating Anxiety and Mood Disorders
US7855195B2 (en) * 2003-12-02 2010-12-21 Pharmaneuroboost N.V. Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
US7884096B2 (en) * 2003-12-02 2011-02-08 Pharmaneuroboost N.V. Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
CA2547639A1 (en) * 2003-12-02 2005-06-16 B&B Beheer Nv Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists
JP2009511606A (ja) 2005-10-14 2009-03-19 ハー・ルンドベック・アクチエゼルスカベット エスシタロプラムおよびブプロピオンの低用量の併用を用いる中枢神経系障害の治療方法
US20070134322A1 (en) * 2005-12-14 2007-06-14 Forest Laboratories, Inc. Modified and pulsatile release pharmaceutical formulations of escitalopram
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143702A (tr) * 1965-03-18
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
US4439545A (en) 1981-11-19 1984-03-27 Societe D "Expansion Scientifique "Expansia" Acrylic copolymers of N-acryloylpolymethyleneimines or N-acryloyldialkylamides, N,N'-acryloyldiaminoalcanes and N-acryloylaminoacids (or esters) their preparation and use as cation exchangers
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8607313D0 (en) * 1986-03-25 1986-04-30 Ici Plc Pharmaceutical compositions
GB8814057D0 (en) 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US4902710A (en) * 1988-12-14 1990-02-20 Eli Lilly And Company Serotonin and norepinephrine uptake inhibitors
US5114976A (en) * 1989-01-06 1992-05-19 Norden Michael J Method for treating certain psychiatric disorders and certain psychiatric symptoms
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
DK213290D0 (da) 1990-09-06 1990-09-06 Lundbeck & Co As H Treatment of cerebrovascular disorders
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
US5708035A (en) * 1991-02-04 1998-01-13 Sepracor Inc. Methods of use and compositions of R(-) fluoxetine
WO1992018005A1 (en) 1991-04-16 1992-10-29 National Institutes Of Health Method of treating trichotillomania and onychophagia
CA2123704C (en) 1991-11-15 2003-01-21 James W. Young Methods and compositions utilizing pure s(+)isomer fluoxetine
EP0714663A3 (en) 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
US5627196A (en) * 1995-01-17 1997-05-06 Eli Lilly And Company Compounds having effects on serotonin-related systems
WO1996024353A1 (en) * 1995-02-10 1996-08-15 Eli Lilly And Company Methods of treating or preventing psychiatric disorders
US5554383A (en) * 1995-04-06 1996-09-10 Trustees Of Tufts College Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination
DE69607904T2 (de) 1995-08-16 2000-10-05 Lilly Co Eli Potenzierung von Serotonin-Wirkstoffresponz
US5846982A (en) * 1996-06-14 1998-12-08 Eli Lilly And Company Inhibition of serotonin reuptake
US5912256A (en) * 1996-06-20 1999-06-15 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5747494A (en) * 1996-06-28 1998-05-05 U C B S.A. Pharmaceutical compositions for the treatment of depressive disorders
US5958429A (en) * 1996-08-16 1999-09-28 Eli Lilly And Company Potentiation of serotonin response
ZA977967B (en) * 1996-09-23 1999-03-04 Lilly Co Eli Combination therapy for treatment of psychoses
US5776969A (en) * 1997-02-27 1998-07-07 Eli Lilly And Company Treatment of sleep disorders
US6069177A (en) * 1997-07-08 2000-05-30 The Hong Kong University Of Science And Technology 3-Hydroxy-propanamine derived neuronal reuptake inhibitors
SE9703375D0 (sv) * 1997-09-18 1997-09-18 Astra Ab A new combination
SE9703379D0 (sv) * 1997-09-18 1997-09-18 Astra Ab New compounds
JP3813820B2 (ja) * 1997-11-11 2006-08-23 ハー・ルンドベック・アクチエゼルスカベット シタロプラムの製造方法
ES2188095T3 (es) * 1998-04-15 2003-06-16 Pfizer Prod Inc Carboxamidas heterociclicas.
EP1100501A4 (en) * 1998-06-30 2002-12-04 Lilly Co Eli PYRROLIDINE AND PYRROLIDINE DERIVATIVES INFLUENTING THE SYSTEMS ASSOCIATED WITH SEROTONIN
CA2336962A1 (en) 1998-07-13 2000-01-20 Alan Mueller Methods and compounds for treating depression and other disorders
US6579899B1 (en) 1998-07-16 2003-06-17 Massachusetts Institute Of Technology Composition for treatment of stress
EP1096927A4 (en) 1998-07-16 2002-09-04 Massachusetts Inst Technology STRESS TREATMENT COMPOSITION
US6150376A (en) * 1998-08-05 2000-11-21 Georgetown University Bi- and tri-cyclic aza compounds and their uses
SE9803157D0 (sv) 1998-09-16 1998-09-16 Astra Ab A new composition
SE9803158D0 (sv) * 1998-09-16 1998-09-16 Astra Ab A new composition
EA002977B1 (ru) * 1998-10-20 2002-12-26 Х.Лундбекк А/С Способ получения циталопрама
AR021509A1 (es) * 1998-12-08 2002-07-24 Lundbeck & Co As H Derivados de benzofurano, su preparacion y uso
ES2195554T5 (es) * 1999-04-14 2010-02-02 H. Lundbeck A/S Metodo para la preparacion de citalopram.
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
US6333357B1 (en) * 1999-11-05 2001-12-25 Be Able, Llc Behavior chemotherapy
UA77650C2 (en) * 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
EP1276478A2 (en) * 2000-04-24 2003-01-22 ARYx Therapeutics (2-aminoethyl) oxime derivatives for the treatment of depression
JP2002361405A (ja) * 2000-09-25 2002-12-18 Showa Denko Kk 熱交換器の製造方法
US20040198809A1 (en) * 2001-05-01 2004-10-07 Connie Sanchez Use of enantiomeric pure escitalopram

Also Published As

Publication number Publication date
US20040029957A1 (en) 2004-02-12
DE60030861T2 (de) 2007-05-03
BG106279A (bg) 2002-08-30
AU782514B2 (en) 2005-08-04
US20040029956A1 (en) 2004-02-12
EP1440691A3 (en) 2004-08-25
US20070276035A1 (en) 2007-11-29
NO329021B1 (no) 2010-07-26
CA2687394A1 (en) 2001-01-18
AU2005202684A1 (en) 2005-07-14
EP1440691A2 (en) 2004-07-28
TR200402276T2 (tr) 2005-01-24
CL2008003939A1 (es) 2009-06-05
CL2008003938A1 (es) 2009-05-22
WO2001003694A1 (en) 2001-01-18
DK1200081T3 (da) 2006-12-27
PT1200081E (pt) 2007-01-31
JP4773011B2 (ja) 2011-09-14
DE60030861D1 (de) 2006-11-02
BG110468A (en) 2010-01-29
CA2687396A1 (en) 2001-01-18
NO20020062L (no) 2002-01-07
SI1200081T1 (sl) 2007-02-28
IL146131A0 (en) 2002-07-25
CA2373757C (en) 2010-01-05
BG110466A (en) 2010-01-29
BG110467A (en) 2010-01-29
CL2008003941A1 (es) 2009-05-22
AR021155A1 (es) 2002-06-12
HUP0201791A3 (en) 2005-02-28
BR0011578A (pt) 2002-03-26
EP1440689A3 (en) 2004-08-25
ATE339955T1 (de) 2006-10-15
KR20020015346A (ko) 2002-02-27
SK82002A3 (en) 2002-07-02
HRP20010820A2 (en) 2003-08-31
IL170193A (en) 2010-04-29
CZ200270A3 (cs) 2002-04-17
US20040029958A1 (en) 2004-02-12
AU2005202686B2 (en) 2009-01-15
KR100604176B1 (ko) 2006-07-25
PL352030A1 (en) 2003-07-28
YU78701A (sh) 2004-03-12
NO20020062D0 (no) 2002-01-07
MXPA01011626A (es) 2002-06-04
CA2687392A1 (en) 2001-01-18
AU2008264182A1 (en) 2009-01-29
NO20100333L (no) 2002-01-07
NO20100334L (no) 2002-01-07
MY143278A (en) 2011-04-15
TR200402275T2 (tr) 2005-03-21
JP2003504332A (ja) 2003-02-04
AU2005202685B2 (en) 2009-01-15
MEP2508A (xx) 2010-02-10
US20050101665A1 (en) 2005-05-12
US20020086899A1 (en) 2002-07-04
US6960613B2 (en) 2005-11-01
IS6137A (is) 2001-10-30
US7265151B2 (en) 2007-09-04
TWI232101B (en) 2005-05-11
AU5806100A (en) 2001-01-30
US7271194B2 (en) 2007-09-18
EP1440689A2 (en) 2004-07-28
EP1200081B1 (en) 2006-09-20
EA200200137A1 (ru) 2002-06-27
EP1440690A3 (en) 2004-08-18
AU2005202686A1 (en) 2005-07-14
UA77645C2 (en) 2007-01-15
CY1105806T1 (el) 2011-02-02
TR200200014T2 (tr) 2002-05-21
AU2005202685A1 (en) 2005-07-14
ME00032B (me) 2010-02-10
IL170194A (en) 2010-05-31
ES2272298T3 (es) 2007-05-01
AU2005202684B2 (en) 2009-01-15
CN1198610C (zh) 2005-04-27
IL146131A (en) 2007-02-11
EP1200081A1 (en) 2002-05-02
EP1440690A2 (en) 2004-07-28
ZA200108856B (en) 2002-12-24
AU2008264188A1 (en) 2009-05-07
CO5190674A1 (es) 2002-08-29
EA006555B1 (ru) 2006-02-24
CA2373757A1 (en) 2001-01-18
HK1048069B (zh) 2005-12-16
HK1048069A1 (en) 2003-03-21
CN1360501A (zh) 2002-07-24
NO20100335L (no) 2002-01-07
HUP0201791A2 (en) 2002-10-28
IL170192A (en) 2010-04-29

Similar Documents

Publication Publication Date Title
TR200402276T2 (tr) Nörotik düzensizliklerin tedavisi
BR0207760A (pt) Composição farmacêutica, uso da mesma, métodos para o tratamento de dor e de inflamação, e, processo para a preparação de uma composição
ATE381323T1 (de) Pharmazeutische zusammensetzungen enthaltend flavonoide und menthol
GEP20053602B (en) Aripiprazole for Oral Administration
SE9703693D0 (sv) Novel combination
HRP20010877B1 (en) Composition for prevention and treatment of amyloidogenic disease
CY1109238T1 (el) Δισκιο περιεχον σετιριζινη και ψευδοεφεδρινη
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
PT1228028E (pt) Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
BRPI0411176A (pt) combinação farmacêutica consistindo de modafinil e outra droga
ATE318610T1 (de) Orale zusammensetzungen zur behandlung von kopfhauterkrankungen
AR034493A1 (es) Combinacion de principios activos para el tratamiento medico de toxicomanias.
BR0210650A (pt) Tablete, e, uso do mesmo
BR0317539A (pt) Métodos e composições para o tratamento de infecções por vìrus da herpes usando inibidores seletivos da ou ciclooxigenase-2 ou inibidores da ciclooxigenase-2 em combinação com agentes antivirais
BR0115882A (pt) Emprego de compostos de 1-fenil-3-dimetilaminopropano no tratamento da incontinência urinária
BR0111897A (pt) Composto, método para tratar um indivìduo afligido por alguns distúrbios dos sistemas nervosos periférico e central, composição farmacêutica, e, uso de um composto
BR0010560A (pt) 3-piridil-4-arilpirrois substituìdos e métodos terapêuticos e profiláticos relacionados
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
BR0214060A (pt) Uso de monoidroxicarbamazepina em distúrbio afetivo e de atenção e dor neuropática
DE60236443D1 (de) Inhibitoren der kostimulation via ox40 und deren verwendung gegen eine von virusen induzierten immunpathologie
DE60003074D1 (de) Fusidinsäure-derivate
BR0211533A (pt) Tratamento de dor crÈnica com 3-heterociclil- e 3-cicloalquil-3-ariloxipropanaminas
DE50207436D1 (de) Verwendung von 5-substituierten nukleosiden und/oder deren prodrugs zur resistenzfreien therapie von infektionskrankheiten
PT1206267E (pt) Medicamentos contendo oligo-ou/e polirribonucleotidos xenogenicos
ATE387913T1 (de) Xenogene oligo- oder/und polyribonukleotide als mittel zur behandlung von malignen tumoren